Your session is about to expire
← Back to Search
Contact Lenses
kalifilcon A Daily Disposable Toric for Near-sightedness
N/A
Waitlist Available
Research Sponsored by Bausch & Lomb Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one week
Awards & highlights
Study Summary
Experienced soft contact lens wearing subjects will be enrolled in this 1-week, confirmatory, randomized, bilateral, 2-way crossover, double masked (subject and investigator), repeated measures, dispensing study. All subjects will be seen for a Screening/Baseline Visit at which informed consent will be obtained and eligibility will be assessed.
Eligible Conditions
- Near-sightedness
- Astigmatism
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one week
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Visual Acuity
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: kalifilcon A Daily Disposable ToricExperimental Treatment1 Intervention
kalifilcon A Daily Disposable Toric
Group II: Ultra for Astigmatism Contact LensesActive Control1 Intervention
Ultra for Astigmatism Contact Lenses
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
kalifilcon A Daily Disposable Toric
2022
N/A
~30
Find a Location
Who is running the clinical trial?
Bausch & Lomb IncorporatedLead Sponsor
251 Previous Clinical Trials
57,388 Total Patients Enrolled
Robert SteffenStudy DirectorBausch & Lomb Incorporated
2 Previous Clinical Trials
835 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger